Ms. Wallace brings over 15 years of business experience in healthcare to Kezar’s board. She is currently a Venture Partner at Third Rock Ventures, where she focuses on the formation, development, and strategy of Third Rock portfolio companies. Prior to Third Rock, Courtney was an early employee and the Chief Business Officer of Beam Therapeutics, a biotechnology company focused on precision genetic medicine. While at Beam, Courtney had oversight of business development and alliances, corporate strategy, new product planning, and other business functions. These efforts contributed over $400M in non-dilutive capital to the company. Prior to Beam, Courtney was in positions of increasing responsibility at Celgene Corporation, where she was responsible for leading collaborations, licensing transactions, equity investments, and mergers and acquisitions across a variety of therapeutic areas. Earlier in her career, Courtney was a consultant for Easton Associates, where she advised biotechnology and pharmaceutical companies on general corporate strategy, pipeline and portfolio planning, clinical development, sales and marketing activities, and business development. Courtney holds an MBA from Harvard Business School and an AB from Harvard College.